Media 01
Congress should base patent policy on evidence, not accusations
Lawmakers must reject I-MAK’s questionable data and abandon two damaging bills, the Drug Competition Enhancement Act and Affordable Prescriptions for Patients Act.
To Defend Nations, NATO Must Defend Innovation
In a new piece for Newsweek, Mircea Geoană, former NATO deputy secretary general and president of the Aspen Institute Romania, and Andrei Iancu, C4IP co-chair
Patent Eligibility Restoration Act Would Fuel US Competitiveness
In a recent op-ed for Bloomberg Law, C4IP Board Members and retired Federal Circuit Judges Paul Michel and Kathleen O’Malley argue that Congress must pass
Council for Innovation Promotion Statement on RALIA and the BIA
WASHINGTON (November 10, 2025) — Recently, Representatives Thomas Massie (R-KY), Marcy Kaptur (D-OH), Michael Cloud (R-TX), Warren Davidson (R-OH), Paul Gosar (R-AZ), and Chip Roy
Council for Innovation Promotion Urges Caution Regarding I-MAK’s New Report on Patents and Drug Pricing
WASHINGTON (October 20, 2025) — Today, the Council for Innovation Promotion (C4IP) Executive Director Frank Cullen released the following statement regarding a new report from
Council for Innovation Promotion Publishes New Website Addressing I-MAK Myths
WASHINGTON (September 18, 2025) — Today, the Council for Innovation Promotion (C4IP) launched www.I-MAKexposed.com, a new website to combat the patent misinformation spread by the